XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Fair Value of Financial Instruments - Change In Fair Value, Contingent Liabilities (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Change in fair value        
Loss on debt extinguishment $ 730,000   $ 560,000  
Related Party Receivable        
Change in fair value        
Change in fair value 140,000      
Reclass contingent earn-out receivable, related party to related party receivable 1,430,000   1,430,000  
Fair Value, Net Derivative Asset (Liability), Balance at the ending 1,570,000   1,570,000  
Contingent Consideration Receivable | Discontinued Operations, Disposed of by Sale | Elusys Therapeutics        
Change in fair value        
Fair Value, Net Derivative Asset (Liability), Balance at the beginning     268,000  
Issuance of convertible promissory note, related party, assets     (268,000)  
Consideration Earn-out Receivable | Discontinued Operations, Disposed of by Sale | Elusys Therapeutics        
Change in fair value        
Fair Value, Net Derivative Asset (Liability), Balance at the beginning     1,720,000  
Loss on partial extinguishment     (1,480,000)  
Change in fair value     1,190,000  
Reclass contingent earn-out receivable, related party to related party receivable     (1,430,000)  
Consideration Earn-out Receivable | Elusys Therapeutics | Discontinued Operations, Disposed of by Sale        
Change in fair value        
Fair Value, Net Derivative Asset (Liability), Balance at the beginning 2,720,000      
Loss on partial extinguishment (1,480,000)      
Change in fair value 190,000      
Reclass contingent earn-out receivable, related party to related party receivable (1,430,000)      
Contingent consideration | Pelican Therapeutics, Inc.        
Change in fair value        
Balance at the beginning   $ 12,334,115   $ 12,224,614
Payment of contingent consideration   (100,344)   (100,344)
Change in fair value   (286,855)   (177,354)
Reclassification to held for sale   $ (11,946,916)   $ (11,946,916)
Convertible and non-convertible promissory notes, related party        
Change in fair value        
Fair Value, Net Derivative Asset (Liability), Balance at the beginning (2,680,000)      
Gain on partial extinguishment 750,000   (920,000)  
Change in fair value (130,000)   (244,250)  
Fair Value, Net Derivative Asset (Liability), Balance at the ending (2,060,000)   (2,060,000)  
Convertible and non-convertible promissory notes, related party | Related Party Receivable        
Change in fair value        
Change in fair value     140,000  
Fair Value, Net Derivative Asset (Liability), Balance at the ending $ 1,570,000   1,570,000  
Convertible promissory note, related party        
Change in fair value        
Issuance of convertible promissory note, related party, assets     (1,985,750)  
Non-convertible promissory note, related party        
Change in fair value        
Issuance of convertible promissory note, related party, assets     $ (750,000)